Expression of c-Met in laryngeal carcinoma

Motohiro Sawatsubashi, Eizaburo Sasatomi, Hiroyuki Mizokami, Osamu Tokunaga, Takemoto Shin

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Expression of c-Met, a gene for the hepatocyte growth factor/scatter factor (HGF/SF) receptor, is known to be associated with tumour development in several human carcinomas. The expression of c-Met was examined using immunohistochemistry in 82 cases of primary laryngeal carcinoma to evaluate the tissue distribution of c-Met and the clinicopathological significance of c-Met expression. In normal larynx, c-Met expression was observed only in some minor salivary glands. Positive reaction for c-Met in neoplastic epithelium was noted in 45 out of 82 (54.9%) cases. In 44 cases, structures adjacent to the carcinoma (noncancerous squamous epithelium, some stromal fibroblastic cells, and endothelial cells) showed positive reaction for c-Met. c-Met expression in cancerous epithelium was significantly correlated with lymph node status (P < 0.04) and proliferating activity expressed by the Ki-67 labelling index (P < 0.02). There was no correlation between c-Met expression and age, sex, histological type, T category, distant metastasis or clinical stage. The data suggest that overexpression of c-Met in laryngeal carcinomas represents a growth advantage for cancer cells, which may be conferred by the mitogenic effect of HGF/SF. Simultaneous c-Met expression in noncancerous components of the larynx may represent a paracrine modification of c-Met.

Original languageEnglish
Pages (from-to)331-335
Number of pages5
JournalVirchows Archiv
Volume432
Issue number4
DOIs
Publication statusPublished - Apr 28 1998
Externally publishedYes

Fingerprint

Hepatocyte Growth Factor
Epithelium
Larynx
Carcinoma
Proto-Oncogene Proteins c-met
Minor Salivary Glands
Tissue Distribution
Stromal Cells
Squamous Cell Carcinoma
Neoplasms
Endothelial Cells
Lymph Nodes
Immunohistochemistry
Neoplasm Metastasis
Growth
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Sawatsubashi, M., Sasatomi, E., Mizokami, H., Tokunaga, O., & Shin, T. (1998). Expression of c-Met in laryngeal carcinoma. Virchows Archiv, 432(4), 331-335. https://doi.org/10.1007/s004280050174

Expression of c-Met in laryngeal carcinoma. / Sawatsubashi, Motohiro; Sasatomi, Eizaburo; Mizokami, Hiroyuki; Tokunaga, Osamu; Shin, Takemoto.

In: Virchows Archiv, Vol. 432, No. 4, 28.04.1998, p. 331-335.

Research output: Contribution to journalArticle

Sawatsubashi, M, Sasatomi, E, Mizokami, H, Tokunaga, O & Shin, T 1998, 'Expression of c-Met in laryngeal carcinoma', Virchows Archiv, vol. 432, no. 4, pp. 331-335. https://doi.org/10.1007/s004280050174
Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O, Shin T. Expression of c-Met in laryngeal carcinoma. Virchows Archiv. 1998 Apr 28;432(4):331-335. https://doi.org/10.1007/s004280050174
Sawatsubashi, Motohiro ; Sasatomi, Eizaburo ; Mizokami, Hiroyuki ; Tokunaga, Osamu ; Shin, Takemoto. / Expression of c-Met in laryngeal carcinoma. In: Virchows Archiv. 1998 ; Vol. 432, No. 4. pp. 331-335.
@article{ae54391698ab4dca871709a1f17a971f,
title = "Expression of c-Met in laryngeal carcinoma",
abstract = "Expression of c-Met, a gene for the hepatocyte growth factor/scatter factor (HGF/SF) receptor, is known to be associated with tumour development in several human carcinomas. The expression of c-Met was examined using immunohistochemistry in 82 cases of primary laryngeal carcinoma to evaluate the tissue distribution of c-Met and the clinicopathological significance of c-Met expression. In normal larynx, c-Met expression was observed only in some minor salivary glands. Positive reaction for c-Met in neoplastic epithelium was noted in 45 out of 82 (54.9{\%}) cases. In 44 cases, structures adjacent to the carcinoma (noncancerous squamous epithelium, some stromal fibroblastic cells, and endothelial cells) showed positive reaction for c-Met. c-Met expression in cancerous epithelium was significantly correlated with lymph node status (P < 0.04) and proliferating activity expressed by the Ki-67 labelling index (P < 0.02). There was no correlation between c-Met expression and age, sex, histological type, T category, distant metastasis or clinical stage. The data suggest that overexpression of c-Met in laryngeal carcinomas represents a growth advantage for cancer cells, which may be conferred by the mitogenic effect of HGF/SF. Simultaneous c-Met expression in noncancerous components of the larynx may represent a paracrine modification of c-Met.",
author = "Motohiro Sawatsubashi and Eizaburo Sasatomi and Hiroyuki Mizokami and Osamu Tokunaga and Takemoto Shin",
year = "1998",
month = "4",
day = "28",
doi = "10.1007/s004280050174",
language = "English",
volume = "432",
pages = "331--335",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Expression of c-Met in laryngeal carcinoma

AU - Sawatsubashi, Motohiro

AU - Sasatomi, Eizaburo

AU - Mizokami, Hiroyuki

AU - Tokunaga, Osamu

AU - Shin, Takemoto

PY - 1998/4/28

Y1 - 1998/4/28

N2 - Expression of c-Met, a gene for the hepatocyte growth factor/scatter factor (HGF/SF) receptor, is known to be associated with tumour development in several human carcinomas. The expression of c-Met was examined using immunohistochemistry in 82 cases of primary laryngeal carcinoma to evaluate the tissue distribution of c-Met and the clinicopathological significance of c-Met expression. In normal larynx, c-Met expression was observed only in some minor salivary glands. Positive reaction for c-Met in neoplastic epithelium was noted in 45 out of 82 (54.9%) cases. In 44 cases, structures adjacent to the carcinoma (noncancerous squamous epithelium, some stromal fibroblastic cells, and endothelial cells) showed positive reaction for c-Met. c-Met expression in cancerous epithelium was significantly correlated with lymph node status (P < 0.04) and proliferating activity expressed by the Ki-67 labelling index (P < 0.02). There was no correlation between c-Met expression and age, sex, histological type, T category, distant metastasis or clinical stage. The data suggest that overexpression of c-Met in laryngeal carcinomas represents a growth advantage for cancer cells, which may be conferred by the mitogenic effect of HGF/SF. Simultaneous c-Met expression in noncancerous components of the larynx may represent a paracrine modification of c-Met.

AB - Expression of c-Met, a gene for the hepatocyte growth factor/scatter factor (HGF/SF) receptor, is known to be associated with tumour development in several human carcinomas. The expression of c-Met was examined using immunohistochemistry in 82 cases of primary laryngeal carcinoma to evaluate the tissue distribution of c-Met and the clinicopathological significance of c-Met expression. In normal larynx, c-Met expression was observed only in some minor salivary glands. Positive reaction for c-Met in neoplastic epithelium was noted in 45 out of 82 (54.9%) cases. In 44 cases, structures adjacent to the carcinoma (noncancerous squamous epithelium, some stromal fibroblastic cells, and endothelial cells) showed positive reaction for c-Met. c-Met expression in cancerous epithelium was significantly correlated with lymph node status (P < 0.04) and proliferating activity expressed by the Ki-67 labelling index (P < 0.02). There was no correlation between c-Met expression and age, sex, histological type, T category, distant metastasis or clinical stage. The data suggest that overexpression of c-Met in laryngeal carcinomas represents a growth advantage for cancer cells, which may be conferred by the mitogenic effect of HGF/SF. Simultaneous c-Met expression in noncancerous components of the larynx may represent a paracrine modification of c-Met.

UR - http://www.scopus.com/inward/record.url?scp=0031916892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031916892&partnerID=8YFLogxK

U2 - 10.1007/s004280050174

DO - 10.1007/s004280050174

M3 - Article

VL - 432

SP - 331

EP - 335

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 4

ER -